Showing results (231-240 of 458) with videos related to

Sort By:
Pageof 46
Pediatric Blood & Cancer|August 27, 2010
Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing programHernan Carol, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|August 20, 2013
Initial testing (stage 1) of the Polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing ProgramRichard Gorlick, E Anders Kolb, Stephen T Keir, et al.
Frontiers in Immunology|February 15, 2018
A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope ConformationsJugmohit S Toor, Arjun A Rao, Andrew C McShan, et al.
Pediatric Blood & Cancer|November 20, 2014
Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Stephen T Keir, et al.
Pediatric Blood & Cancer|February 22, 2011
Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing programPeter J Houghton, Richard Gorlick, E Anders Kolb, et al.
Pediatric Blood & Cancer|May 18, 2011
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing programRichard B Lock, Hernan Carol, Christopher L Morton, et al.
Medical and Pediatric Oncology|July 24, 2001
Biological aspects of neuroblastomas identified by mass screening in QuebecG M Brodeur, A T Look, H Shimada, et al.
Pediatric Blood & Cancer|January 11, 2013
Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the Pediatric Preclinical Testing ProgramRichard B Lock, Hernan Carol, John M Maris, et al.
Pageof 46